• Request sample

Diabetes Monitoring Devices Market Synopsis:

Diabetes Monitoring Devices Market Size Was Valued at USD 13.43 Billion in 2023, and is Projected to Reach USD 27.41 Billion by 2032, Growing at a CAGR of 8.25% From 2024-2032.

Diabetes Monitoring Devices Market means the industry that deals in products that help in diagnosis and/or management of diabetes. Blood glucose meters, CGM and insulin delivery devices are among necessary tools patients need for controlling their blood glucose levels. This is because the number of people suffering from diabetes increases with time all over the world hence the need for a better and efficient method of monitoring the condition has led to developments in technology as well as bringing new products in the market.

The global Diabetes Monitoring Devices Market is set to experience rapid growth because of the increasing incidence of diabetes. Currently, there were about 537 million adults living with diabetes in 2021 – according to the IDF – and the number is bound to grow even further. Diabetes mellitus type 2 has continued to rise and, with it, the need for proper monitoring solutions to help manage blood glucose concentrations and envisage potential complications. Other factors that have boosted demand for monitoring devices in individuals with diabetes are a growing sensitization to the illness and enhanced knowledge of its necessary management.

Trends are identified as one of the key factors that affect the Revenue of the Diabetes Monitoring Devices Market, which has been influenced by technological developments. Technological advancements like systems like CGM and smart ID devices in managing diabetes have advanced with some accuracy and efficiency. Smartphone connected wearable technologies are becoming widespread; patients are now able to monitor the real-time glucose level measured by the device and share data with the doctor. Not only do these developments provide increased patient accessibility, but also higher rates of efficiency translate into better health and increased market demand.

Diabetes Monitoring Devices Market - Trends, Size & Outlook (2024-2032)

Diabetes Monitoring Devices Market Trend Analysis:

The increasing adoption of smart and connected devices.

  • One of the driving facts about the Diabetes Monitoring Devices Market is the integration of smart and connected devices. For a long time, diabetes management has been focusing on monitoring procedures that have undergone a major shift due to the incorporation of IoT technology. Commercial devices also permit patients to connect their handhelds with mobile programs, thus achieving total view of glucose amounts, medication, and foodstuff. Such threats promote health literacy as patients get to access information and timely notifications that assist them to comprehend their therapies.
  • The second major trend is the shift toward individualized approaches to diabetes treatment hits the spot. Device makers are creating devices adapted to the specific patients with a view to their daily routine, physical activity, and food intake. This concept helps improve compliance to the treatments and expand the satisfaction of the patients. Since patient-centricity is becoming more prevalent in today’s healthcare management systems, the need for specialized diabetes tracking tools cannot but rise.

The expanding geriatric population.

  • The rising prevalence of diabetes along with the ageing population across the global geography poses risks as well as a major opportunity for the Diabetes Monitoring Devices Market. Diabetes management becomes a massive concern as people age necessitating better and enhanced monitoring tools for this population. Any firm that is able to design small, comfortable, and particularly informational machines and equipment for the elderly patients has the market ready for consumption. Also, to the integration of telehealth solutions in diabetes management devices can help people with this disease to have access to care, any again contributing to the market development.
  • Asia Pacific and Latin AMericas remain promising markets for expansion because they are relatively new players in the global arena. Due to improved standard of living, inclination towards better health care, and booming diabetic population in these regions, there is huge market for cost effective diabetic management solutions. Businesses that positioning themselves in these markets and directing their products according to local requirements can provide a significant part of the continuously increasing diabetes monitoring devices market.

Diabetes Monitoring Devices Market Segment Analysis:

Diabetes Monitoring Devices Market Segmented on the basis of type, application and end user.

By Type, Blood Glucose Meters segment is expected to dominate the market during the forecast period

  • The Diabetes Monitoring Devices Market is categorized based on the type of device and includes different products which play important roles in diabetes management. SMBGs are the most common type of home use glucometers, they enable patients to monitor the disease on their own without the need for professional help. CGM systems give real time glucose value and pattern throughout the day, which is more beneficial than just knowing random glucose value, and which allows for early interventions if necessary. Reusable insulin pens and insulin pump represent major types of insulin delivery devices to deliver accurate and convenient dosages of insulin. Others devices in this segment might be auxiliary like lancets, test strips, and computer applications helping in diabetes management addressing more to a great approach to managing diabetes.

By Technology, Wearable Devices segment expected to held the largest share

  • The Diabetes Monitoring Devices Market is categorized based on the technology applied in three main types that improve the diabetes management. SMBG devices are convention glucometers that give the patient an instantaneous blood glucose measurement for self-management from a fingerstick blood sample. Mobile devices for diabetes, for example smart watches and CGMs give the benefit of monitoring glucose levels over time, further they provide integration with an associated mobile app to give real time updates. Another and rarer form of Augmentation is through implantation of devices that more frequently directly record the glucose levels of blood within the body and relay the information to the patients themselves and the healthcare providers as needed.

Diabetes Monitoring Devices Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • Diabetes Monitoring Devices Market is dominated more by North America with around 40 % market share of the global market. Such dominance is explained by higher levels of diagnosed diabetes, well-developed health care systems, and favourable reimbursement rates for diabetes care products. The research a development environment and the market presence of various key players also contribute to strengthening the regions dominance in the market.
  • Moreover, North America offers a good distribution channel network and high customer awareness of diabetic management. From the guidelines more involvement of the patient is observed on the use of technology, in particular smart apps and telemedicine in diabetes management and urge the use of monitoring devices. For this reason, the Diabetes Monitoring Devices Market is expected to remain dominated by North America for the near future.

Active Key Players in the Diabetes Monitoring Devices Market:

  • Abbott Laboratories (United States)
  • Medtronic plc (Ireland)
  • Dexcom, Inc. (United States)
  • Roche Diabetes Care (Switzerland)
  • Johnson & Johnson (United States)
  • Ascensia Diabetes Care (Switzerland)
  • Becton, Dickinson and Company (United States)
  • Sanofi (France)
  • Ypsomed AG (Switzerland)
  • Siemens Healthineers (Germany)
  • Other Active Players

Diabetes Monitoring Devices Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 13.43 Billion

Forecast Period 2024-32 CAGR:

 8.25%

Market Size in 2032:

USD 27.41 Billion

Segments Covered:

By Type

  • Blood Glucose Meters
  • Continuous Glucose Monitoring (CGM) Systems
  • Insulin Delivery Devices
  • Other Devices

By Technology

  • Self-Monitoring Blood Glucose (SMBG)
  • Wearable Devices
  • Implantable Devices

End User

  • Hospitals
  • Homecare Settings
  • Diagnostic Centers
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Patient Awareness and Education.

Key Market Restraints:

  • Regulatory Challenges and Compliance Issues.

Key Opportunities:

  • Integration of Telehealth Solutions.

Companies Covered in the report:

  • Abbott Laboratories (United States), Medtronic plc (Ireland), Dexcom, Inc. (United States), Roche Diabetes Care (Switzerland), Johnson & Johnson (United States), Ascensia Diabetes Care (Switzerland), Becton, Dickinson and Company (United States), Sanofi (France), Ypsomed AG (Switzerland), Siemens Healthineers (Germany). and Other Active Players.
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Diabetes Monitoring Devices Market research report?

The forecast period in the Diabetes Monitoring Devices Market research report is 2024-2032.

Who are the key players in the Diabetes Monitoring Devices Market?
What are the segments of the Diabetes Monitoring Devices Market?
What is the Diabetes Monitoring Devices Market?
How big is the Diabetes Monitoring Devices Market?